CLINICAL, PARACLINICAL CHARACTERISTICS AND SURGICAL OUTCOMES OF VENTRICULOPERITONEAL SHUNT IN PATIENTS WITH HYDROCEPHALUS AT NGHE AN GENERAL FRIENDSHIP HOSPITAL)

Hồng Việt Nguyễn , Kim Tuấn Hoàng , Ngọc Hùng Nguyễn

Main Article Content

Abstract

Objective: To evaluate the treatment outcomes of ventriculoperitoneal (VP) shunt surgery in patients with hydrocephalus at Nghe An General Friendship Hospital. Subjects and methods: A retrospective cross-sectional study was conducted on 83 medical records of patients aged ≥18 years who were diagnosed with hydrocephalus and underwent VP shunt surgery at the hospital. The analysis focused on two objectives: (1) Clinical and paraclinical characteristics of patients undergoing surgery; and (2) Treatment outcomes at postoperative time points: immediately after surgery, 1 month, and 3 months. Results: The mean age was 49.9 years, with a male-to-female ratio of 3:1. The most common reasons for admission were headache (83.1%) and altered consciousness (78.0%). Obstructive hydrocephalus accounted for 88.0% of cases. Clinically, 50.6% presented with motor weakness, 34.9% with pyramidal tract signs, and 6.0% with Hakim’s triad. Imaging findings included Evans Index (FH/ID) ≥ 0.5 in 72.3%, “Mickey Mouse ears” sign in 95.2%, temporal horn width >2mm in 96.4%, and periventricular cerebrospinal fluid (CSF) transependymal flow in 92.8%. Positive CSF cultures were found in 1.2% of patients. The mean operative time was 52 minutes. Postoperative complications were minimal, with 91.6% of patients experiencing no complications. Good neurological outcomes (GOS IV–V) were observed in 60.2%, 89.2%, and 90.4% of patients immediately post-surgery, at 1 month, and at 3 months, respectively. Significant improvements in consciousness and general condition were noted at 1 and 3 months compared to immediately after surgery. Conclusion: Ventriculoperitoneal shunt surgery was performed safely, with a low rate of complications and significant improvement in neurological function, consciousness, and general condition over time.

Article Details

References

Anwar F, Zhang K, Sun C, et al. Hydrocephalus: An update on latest progress in pathophysiological and therapeutic research. Biomed Pharmacother. 2024;181:117702. doi:10. 1016/j.biopha.2024.117702
2. Isaacs AM, Riva-Cambrin J, Yavin D, et al. Age-specific global epidemiology of hydrocephalus: Systematic review, metanalysis and global birth surveillance. Cheungpasitporn W, ed. PLOS ONE. 2018;13(10):e0204926. doi:10. 1371/journal.pone.0204926
3. cerevasc. Management of Adult Hydrocephalus With Ventriculoperitoneal Shunts: Long-Term Single-Institution Experience. CereVasc | Neurological Disease Device Company. October 1, 2011. Accessed July 30, 2025. https://cerevasc.com/management-adult-hydrocephalus-ventriculoperitoneal-shunts-long-term-single-institution-experience/
4. Forsberg L. Outcomes of hydrocephalus ventriculoperitoneal shunt surgery at a rural hospital. Published online February 24, 2022. Accessed July 30, 2025. https://gupea.ub.gu.se/ handle/2077/70803
5. Phạm Văn Bính. Điều trị não ung thuỷ ở người lớn bằng phương pháp dẫn lưu não thất ổ bụng. Luận Văn Chuyên Khoa Cấp II Trường Đại Học Hà Nội. Published online 2020.
6. Phan Tiến Thành. Kết quả điều trị não úng thủy bằng phẫu thuật dẫn lưu não thất - ổ bụng với van tẩm kháng sinh. Luận Văn Thạc Sĩ Học Trường Đại Học Hà Nội. Published online 2023.
7. Salih A, Arif A, Varadpande M, et al. The effectiveness of various CSF diversion surgeries in idiopathic normal pressure hydrocephalus: a systematic review and meta-analysis. eClinicalMedicine. 2024;77. doi:10.1016/j.eclinm. 2024.102891
8. Pearce RKB, Gontsarova A, Richardson D, et al. Shunting for idiopathic normal pressure hydrocephalus. Cochrane Z_INACTIVE_Dementia and Cognitive Improvement Group, ed. Cochrane Database Syst Rev. 2024;2024(8). doi:10.1002/ 14651858.CD014923.pub2
9. Popal AM, Zhu Z, Guo X, et al. Outcomes of Ventriculoperitoneal Shunt in Patients With Idiopathic Normal-Pressure Hydrocephalus 2 Years After Surgery. Front Surg. 2021;8:641561. doi:10.3389/fsurg.2021.641561